| Record Information |
|---|
| Version | 1.0 |
|---|
| Creation date | 2010-04-08 22:09:55 UTC |
|---|
| Update date | 2019-11-26 03:05:50 UTC |
|---|
| Primary ID | FDB011961 |
|---|
| Secondary Accession Numbers | Not Available |
|---|
| Chemical Information |
|---|
| FooDB Name | Bisdemethoxycurcumin |
|---|
| Description | Isolated from Curcuma zedoaria (zedoary) and Curcuma longa (turmeric)
Bisdemethoxycurcumin is a curcuminoid, a component of tumeric. Tumeric is a spice that comes from the root Curcuma longa, a member of the ginger family, Zingaberaceae. It is bright yellow and has been used as a coloring agent in food in the United States. In India, it has been used for centuries as a spice and a food preservative, and also for its various medicinal properties. In Ayurveda (Indian traditional medicine), tumeric has been used for its medicinal properties for various indications and through different routes of administration. It has been used topically on the skin for wounds, blistering diseases such as pemphigus and herpes zoster, for parasitic skin infections, and for acne. It has been used via oral administration for the common cold, liver diseases, urinary tract diseases, and as a blood purifier. For chronic rhinitis and coryza, it has been used via inhalation. The average intake of tumeric in the diet in India is approximately 2 to 2.5 g in a 60 kg individual. This corresponds to an intake of approximately 60 to 100 mg of curcumin daily. The Food and Drug Administration has classified tumeric among substances Generally Recognized as Safe (GRAS). A large number of in vitro and animal studies have been conducted to evaluate the effect of curcumin on inflammation. It has been found to act at various different levels of the arachadonic acid inflammatory cascade and through effects on various enzymes and cytokines. (PMID: 12676044) [HMDB]. Bisdemethoxycurcumin is found in turmeric and herbs and spices. |
|---|
| CAS Number | 24939-16-0 |
|---|
| Structure | |
|---|
| Synonyms | | Synonym | Source |
|---|
| 1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione | ChEBI | | 1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione, 9CI | db_source | | 1,7-Bis(4-hydroxyphenyl)-1,6-heptadiene-3,5-dione(e,e) | HMDB | | Bis-demethoxycurcumin | hmdb | | Bis(4-hydroxycinnamoyl)methane | hmdb | | Bis(p-hydroxycinnamoyl)methane | hmdb | | Bisdemethoxycurcumin | db_source | | Bisdesmethoxycurcumin | manual | | Curcumin III | ChEBI | | Didemethoxycurcumin | ChEBI | | p,p'-Dihydroxydicinnamoylmethane | db_source |
|
|---|
| Predicted Properties | |
|---|
| Chemical Formula | C19H16O4 |
|---|
| IUPAC name | (1E,4Z,6E)-5-hydroxy-1,7-bis(4-hydroxyphenyl)hepta-1,4,6-trien-3-one |
|---|
| InChI Identifier | InChI=1S/C19H16O4/c20-16-7-1-14(2-8-16)5-11-18(22)13-19(23)12-6-15-3-9-17(21)10-4-15/h1-13,20-22H/b11-5+,12-6+,18-13- |
|---|
| InChI Key | YXAKCQIIROBKOP-HSSGTREWSA-N |
|---|
| Isomeric SMILES | O\C(\C=C\C1=CC=C(O)C=C1)=C/C(=O)/C=C/C1=CC=C(O)C=C1 |
|---|
| Average Molecular Weight | 308.3279 |
|---|
| Monoisotopic Molecular Weight | 308.104859 |
|---|
| Classification |
|---|
| Description | Belongs to the class of organic compounds known as curcuminoids. These are aromatic compounds containing a curcumin moiety, which is composed of two aryl buten-2-one (feruloyl) chromophores joined by a methylene group. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Phenylpropanoids and polyketides |
|---|
| Class | Diarylheptanoids |
|---|
| Sub Class | Linear diarylheptanoids |
|---|
| Direct Parent | Curcuminoids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Bis-desmethoxycurcumin
- Hydroxycinnamic acid or derivatives
- Styrene
- 1-hydroxy-2-unsubstituted benzenoid
- Phenol
- Monocyclic benzene moiety
- Benzenoid
- Acryloyl-group
- Enone
- Vinylogous acid
- Alpha,beta-unsaturated ketone
- Ketone
- Enol
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organic oxygen compound
- Carbonyl group
- Aromatic homomonocyclic compound
|
|---|
| Molecular Framework | Aromatic homomonocyclic compounds |
|---|
| External Descriptors | Not Available |
|---|
| Ontology |
|---|
| Ontology | No ontology term |
|---|
| Physico-Chemical Properties |
|---|
| Physico-Chemical Properties - Experimental | | Property | Value | Reference |
|---|
| Physical state | Solid | |
|---|
| Physical Description | Not Available | |
|---|
| Mass Composition | C 74.01%; H 5.23%; O 20.76% | DFC |
|---|
| Melting Point | Mp 224° | DFC |
|---|
| Boiling Point | Not Available | |
|---|
| Experimental Water Solubility | Not Available | |
|---|
| Experimental logP | Not Available | |
|---|
| Experimental pKa | Not Available | |
|---|
| Isoelectric point | Not Available | |
|---|
| Charge | Not Available | |
|---|
| Optical Rotation | Not Available | |
|---|
| Spectroscopic UV Data | Not Available | |
|---|
| Density | Not Available | |
|---|
| Refractive Index | Not Available | |
|---|
|
|---|
| Spectra |
|---|
| Spectra | |
|---|
| EI-MS/GC-MS | Not Available |
|---|
| MS/MS | | Type | Description | Splash Key | View |
|---|
| Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Positive | splash10-0a4i-0619000000-04c5e653489d11d272bc | 2016-08-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Positive | splash10-0002-0911000000-45b276752a6ac22386a2 | 2016-08-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Positive | splash10-066v-3900000000-6fb504b278c1fe28ae9d | 2016-08-01 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 10V, Negative | splash10-0a4i-0509000000-d7d0265e261b4033bbda | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 20V, Negative | splash10-0a4i-0905000000-99988579561e10c6b603 | 2016-08-03 | View Spectrum | | Predicted MS/MS | Predicted LC-MS/MS Spectrum - 40V, Negative | splash10-05mo-1910000000-0dbe79994d1f7acb8947 | 2016-08-03 | View Spectrum |
|
|---|
| NMR | Not Available |
|---|
| External Links |
|---|
| ChemSpider ID | 4474770 |
|---|
| ChEMBL ID | CHEMBL105350 |
|---|
| KEGG Compound ID | Not Available |
|---|
| Pubchem Compound ID | 5315472 |
|---|
| Pubchem Substance ID | Not Available |
|---|
| ChEBI ID | Not Available |
|---|
| Phenol-Explorer ID | 715 |
|---|
| DrugBank ID | Not Available |
|---|
| HMDB ID | HMDB02114 |
|---|
| CRC / DFC (Dictionary of Food Compounds) ID | HFR53-E:HCC43-J |
|---|
| EAFUS ID | Not Available |
|---|
| Dr. Duke ID | BIS-DEMETHOXYCURCUMIN|BIS-DESMETHOXYCURCUMIN|DIDESMETHOXYCURCUMIN |
|---|
| BIGG ID | Not Available |
|---|
| KNApSAcK ID | Not Available |
|---|
| HET ID | Not Available |
|---|
| Food Biomarker Ontology | Not Available |
|---|
| VMH ID | Not Available |
|---|
| Flavornet ID | Not Available |
|---|
| GoodScent ID | Not Available |
|---|
| SuperScent ID | Not Available |
|---|
| Wikipedia ID | Not Available |
|---|
| Phenol-Explorer Metabolite ID | Not Available |
|---|
| Duplicate IDS | Not Available |
|---|
| Old DFC IDS | Not Available |
|---|
| Associated Foods |
|---|
| Food | Content Range | Average | Reference |
|---|
| Food | | | Reference |
|---|
|
| Biological Effects and Interactions |
|---|
| Health Effects / Bioactivities | | Descriptor | ID | Definition | Reference |
|---|
| Anti aflatoxin | 35222 | An agent that neutralizes or removes aflatoxins, toxic compounds produced by mold, reducing the risk of liver damage and cancer. Therapeutically, it is used to prevent aflatoxin poisoning, commonly in food safety and liver protection applications, and may have potential in cancer prevention and treatment. | DUKE | | Anti-Alzheimeran | 52217 | An agent that inhibits the progression of Alzheimer's disease, reducing beta-amyloid plaque formation and neuroinflammation. Therapeutically, it improves cognitive function and memory, commonly used in managing mild to moderate Alzheimer's disease and other neurodegenerative disorders. | DUKE | | Anti amyloid-beta | | An agent that targets and reduces amyloid-beta peptides, implicated in Alzheimer's disease, to slow cognitive decline and neurodegeneration, with potential therapeutic applications in Alzheimer's treatment and prevention. | DUKE | | Anti-angiogenic | 48422 | An agent that inhibits the formation of new blood vessels, playing a crucial role in cancer treatment by starving tumors of oxygen and nutrients. Therapeutically, it is used to manage cancer, age-related macular degeneration, and other diseases characterized by excessive angiogenesis, reducing tumor growth and slowing disease progression. | DUKE | | Anti-choleretic | | An agent that inhibits excessive bile production in the liver, reducing bile flow into the intestine. It has therapeutic applications in managing biliary colic, cholecystitis, and other liver disorders, and is used to treat conditions characterized by excessive bile secretion. | DUKE | | Anti-inflammatory | 35472 | An agent that reduces inflammation, playing a biological role in suppressing immune responses and therapeutic applications in managing pain, swelling, and redness. Key medical uses include treating arthritis, allergies, and autoimmune disorders, as well as relieving symptoms of conditions such as asthma and dermatitis. | DUKE | | Anti leishmanic | 33281 | An agent that treats Leishmaniasis, a parasitic disease caused by Leishmania parasites. It kills or inhibits the growth of these parasites, reducing symptoms and preventing disease progression. Therapeutically, anti-leishmanics are used to manage cutaneous, visceral, and mucocutaneous Leishmaniasis, often in combination with other treatments. Key medical uses include treating infected individuals, particularly in endemic regions. | DUKE | | Anti lipoperoxidant | | An agent that prevents peroxidation of lipids, reducing oxidative stress and cell damage. Its biological role involves protecting cell membranes from degradation. Therapeutically, it has applications in managing conditions related to oxidative stress, with key medical uses including neuroprotection, anti-inflammation, and antioxidant therapy. | DUKE | | Anti-mutagenic | | An agent that interferes with the mutagenicity of a substance, preventing DNA damage and mutations. Its biological role is to protect cells from genetic alterations, and it has therapeutic applications in cancer prevention and treatment, as well as key medical uses in reducing the risk of genetic disorders and birth defects. | DUKE | | Anti-nitrosating | | An agent that prevents the formation of nitroso compounds, reducing oxidative stress and inflammation. It plays a biological role in protecting cells from damage. Therapeutically, it has applications in managing cancer, neurodegenerative diseases, and inflammatory disorders, with key medical uses in preventing nitrosative stress and promoting cellular health. | DUKE | | Anti-oxidant | 22586 | An agent that neutralizes free radicals, reducing oxidative stress and cell damage. Its biological role involves protecting cells from harm, and it has therapeutic applications in managing chronic diseases, such as cancer, diabetes, and neurodegenerative disorders, with key medical uses including anti-aging, anti-inflammatory, and cardio protective effects. | DUKE | | Anti-papillomic | 22587 | An agent that targets and inhibits the formation of papillomas, reducing the growth of abnormal cells. Therapeutically, it is used to treat and prevent human papillomavirus (HPV) related diseases, such as cervical cancer and genital warts, by boosting the immune system to fight off the virus. | DUKE | | Antitumor promoter | 35610 | An agent that inhibits tumor growth and progression, reducing cancer cell proliferation. Therapeutically, it prevents tumor development and spread, with key medical uses in cancer prevention and treatment, particularly in combating carcinogenesis and metastasis. | DUKE | | DNA-protective | | An agent that prevents or repairs DNA damage, playing a crucial role in maintaining genomic stability. Therapeutically, it has applications in cancer prevention, neuroprotection, and anti-aging. Key medical uses include reducing chemotherapy-induced DNA damage and mitigating radiation exposure effects. | DUKE | | Nematicide | 25491 | An agent that kills nematodes, a type of parasitic worm, used to control infestations in crops and animals, with therapeutic applications in veterinary medicine to treat parasitic infections and promote livestock health. | DUKE | | Nitric-oxide scavenger | | An agent that retains nitric oxide, reducing its bioavailability. It plays a role in regulating vascular tone and inflammation. Therapeutically, it's used to manage conditions like hypertension and septic shock, with key medical uses including cardiovascular and critical care applications. | DUKE | | Plasmodicide | | An agent that kills malaria parasites, playing a crucial role in treating and preventing malaria. Therapeutically, it targets Plasmodium species, and its key medical uses include prophylaxis and treatment of malaria, particularly in endemic areas, helping to reduce transmission and alleviate disease burden. | DUKE | | Quinone-reductase inducer | | An agent that stimulates quinone reductase enzymatic activity, enhancing cellular antioxidant defenses and protecting against carcinogens, with therapeutic applications in cancer chemoprevention and potential uses in managing oxidative stress-related diseases. | DUKE | | Sortase-A inhibitor | 23924 | An agent that blocks the activity of sortase-A, an enzyme essential for bacterial cell wall assembly, reducing bacterial virulence and infection. Therapeutically, it has applications in treating Gram-positive bacterial infections, particularly those caused by methicillin-resistant Staphylococcus aureus (MRSA). | DUKE | | Topoisomerase-II inhibitor | 50750 | An agent that blocks the activity of topoisomerase-II, an enzyme involved in DNA replication. It prevents cancer cell growth by disrupting DNA structure, commonly used in chemotherapy to treat various types of cancer, including leukemia and lymphoma. | DUKE | | Topoisomerase-I inhibitor | 50276 | An agent that blocks the activity of topoisomerase I, an enzyme involved in DNA replication. It is used therapeutically in cancer treatment, particularly for solid tumors, by inducing DNA damage and inhibiting cancer cell growth, with key medical uses in colorectal, lung, and breast cancers. | DUKE |
|
|---|
| Enzymes | Not Available |
|---|
| Pathways | Not Available |
|---|
| Metabolism | Not Available |
|---|
| Biosynthesis | Not Available |
|---|
| Organoleptic Properties |
|---|
| Flavours | Not Available |
|---|
| Files |
|---|
| MSDS | Not Available |
|---|
| References |
|---|
| Synthesis Reference | Not Available |
|---|
| General Reference | Not Available |
|---|
| Content Reference | — Rothwell JA, Pérez-Jiménez J, Neveu V, Medina-Ramon A, M'Hiri N, Garcia Lobato P, Manach C, Knox K, Eisner R, Wishart D, Scalbert A. (2013) Phenol-Explorer 3.0: a major update of the Phenol-Explorer database to incorporate data on the effects of food processing on polyphenol content. Database, 10.1093/database/bat070. — Duke, James. 'Dr. Duke's Phytochemical and Ethnobotanical Databases. United States Department of Agriculture.' Agricultural Research Service, Accessed April 27 (2004).
|
|---|